AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 271: R254-R261, 1996;
0363-6119/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gellai, M.
Right arrow Articles by Nambi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gellai, M.
Right arrow Articles by Nambi, P.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 1 254-R261, Copyright © 1996 by American Physiological Society


ARTICLES

Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat

M. Gellai, T. Fletcher, M. Pullen and P. Nambi
Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939, USA.

The physiological roles of endothelin-B (ETB) receptor subtypes in systemic and renal hemodynamics were assessed in conscious Sprague-Dawley rats. Mean arterial pressure, hindlimb flow, and renal blood flow were measured via an implanted catheter and pulsed Doppler flow probes. Bolus intravenous injections of sarafotoxin 6c (S6c), a selective ETB agonist, elicited transient dose-dependent vasodilation, followed by sustained vasoconstriction in the systemic bed, but only vasoconstriction in the renal bed. RES-701-1, a selective ETB antagonist, blocked the dilator and potentiated the constrictor effect; SB-209670, a mixed ET receptor antagonist, attenuated both responses to S6c. In follow-up studies, the role of endogenous ET was assessed by administration of the antagonists alone: RES-701-1, SB-209670, and the ETA-selective antagonist BQ-123. RES-701-1 unmasked a significant systemic and renal vasoconstriction, which was attenuated by SB-209670 but not by BQ-123. SB-209670 and BQ-123 had no effect on basal hemodynamic parameters. Data from radioligand binding experiments showed that RES-701-1 binds with high affinity to the cloned human ETB receptor but poorly to the ETB receptor predominant in the rat kidney. Collectively, the results indicate that 1) the vascular effects of ET in the rat are mediated by two ETB receptor subtypes: an RES-701-1-sensitive subtype, mediating vasodilation, and an RES-701-1-insensitive subtype, mediating vasoconstriction; 2) the predominant role of endogenous ET is vasodilation; and 3) the ETA receptor plays a negligible role in the control of vascular tone in the rat.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. L. Thai and W. J. Arendshorst
ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F360 - F368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst
NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Conrad and J. Novak
Emerging role of relaxin in renal and cardiovascular function
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Just, A. J. M. Olson, and W. J. Arendshorst
Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interactions with ETA receptors
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F660 - F668.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. X. Li, M. Bek, L. D. Asico, Z. Yang, D. K. Grandy, D. S. Goldstein, M. Rubinstein, G. M. Eisner, and P. A. Jose
Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice
Hypertension, September 1, 2001; 38(3): 303 - 308.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. A. Danielson, L. J. Kercher, and K. P. Conrad
Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1298 - R1304.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi
Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues
Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. P. Conrad, R. E. Gandley, T. Ogawa, S. Nakanishi, and L. A. Danielson
Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats
Am J Physiol Renal Physiol, May 1, 1999; 276(5): F767 - F776.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. H. Ohlstein, P. Nambi, D. W. P. Hay, M. Gellai, D. P. Brooks, J. Luengo, J.-N. Xiang, and J. D. Elliott
Nonpeptide Endothelin Receptor Antagonists. XI. Pharmacological Characterization of SB 234551, a High-Affinity and Selective Nonpeptide ETA Receptor Antagonist
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 650 - 656.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Kirton and R. Loutzenhiser
Alterations in basal protein kinase C activity modulate renal afferent arteriolar myogenic reactivity
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H467 - H475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Mazzocchi, L. K. Malendowicz, F. G. Musajo, G. Gottardo, A. Markowska, and G. G. Nussdorfer
Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals
Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E1 - E5.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online